v3.26.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:          
Net Income (Loss) $ 2,140 $ 5,205 $ 2,371 $ (746)  
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation, depletion and amortization     24,266 21,634  
Provision (benefit) for deferred income taxes     273 (269)  
Loss on extinguishment of debt 0 0 944 0  
Stock-based compensation     1,689 4,454  
Derivative mark-to-market adjustments and settlements     220 448  
Net (gain) loss on sale or disposal of assets     (13) 36  
Increase in earn-out liability     0 634  
Accretion of asset retirement obligations     389 362 $ 485
Amortization of debt issuance costs 369 98 850 294  
Impairment loss 421 48 1,513 2,472  
Non-cash expense - RINs from equity method investment     9,887 0  
Income from equity method investment (2,637) 0 (9,728) 0 (1,485)
Accounts receivable     3,644 2,154  
Royalty offset long term receivable     (3,297) (4,108)  
Critical spare inventory     (1,275) (1,349)  
Prepaid insurance and expenses     (1,418) (1,257)  
Income tax receivable     (323) (682)  
Accounts payable and Accrued liabilities     16,851 6,366  
Other     79 (446)  
Net cash provided by operating activities     46,922 29,997  
Cash flows from investing activities:          
Capital expenditures     (75,154) (75,106)  
Capital contributions to equity method investments     0 (4,167)  
Cash collateral deposits     0 54  
Proceeds from sale of assets     33 0  
Net cash used in investing activities     (75,121) (79,219)  
Cash flows from financing activities:          
Repayments on long-term debt     (44,000) (9,000)  
Borrowings on long-term debt     155,000 0  
Borrowings on revolver     20,000 40,000  
Repayments on revolver     (105,000) (20,000)  
Debt extinguishment costs     (944) 0  
Debt issuance costs     (5,829) 0  
Common stock issuance     0 4  
Treasury stock purchase     0 (354)  
Contingent consideration payment     0 (176)  
Finance lease payments     (36) (53)  
Net cash provided in financing activities     19,191 10,421  
Net decrease in cash and cash equivalents and restricted cash     (9,008) (38,801)  
Cash and cash equivalents and restricted cash at beginning of period     24,190 46,004 46,004
Cash and cash equivalents and restricted cash at end of period 15,182 7,203 15,182 7,203 24,190
Reconciliation of cash, cash equivalents, and restricted cash at end of period:          
Cash and cash equivalents 12,449 6,766 12,449 6,766 23,752
Restricted cash and cash equivalents - current 8 8 8 8 8
Restricted cash and cash equivalents - non-current 2,725 429 2,725 429 430
Reconciliation of cash, cash equivalents, and restricted cash at end of year $ 15,182 $ 7,203 15,182 7,203 24,190
Supplemental cash flow information:          
Cash paid for interest, net of $7,737 and $550 capitalized respectively     4,118 3,414  
Cash paid for income taxes     232 694  
Accrual for purchase of property, plant and equipment included in accounts payable and accrued liabilities     12,819 18,713  
Non-cash RIN distribution from equity method investment     $ 9,887 $ 0 $ 1,661